Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile

NCT01744730 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Bacterial Infections
Obesity

Interventions

DRUG: Clindamycin

Sponsor

Phillip Brian Smith

Collaborators

[object Object]
[object Object]